Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 4Q Financial Reports: Abbott | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

4Q Financial Reports: Abbott

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott

4Q Revenues: $6 billion (+7%)

4Q Earnings: $976 million (flat)

FY Revenues: $22.3 billion (+13.5%)

FY Earnings: $3.4 billion (+4%)

Comments: Abbott achieved records sales for the quarter and the year. Pharmaceutical Products Group sales grew 10% in the quarter, driven by performance of Humira and contributions from TriCor and Omnicef. Worldwide sales of Humira were $1.4 billion for the year, up 64%. R&D spend was up 7% for the year to $1.8 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters